ICD-10-CM Billable Code

F13.181

Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 Code F13.181 refers to a condition where an individual misuses sedative, hypnotic, or anxiolytic medications, leading to sexual dysfunction. These medications are typically prescribed to help with anxiety, sleep issues, or related conditions, but when abused, they can cause significant health problems, including impacts on sexual health. The combination of substance abuse and sexual problems can affect personal relationships and overall well-being, emphasizing the importance of awareness and proper management.

Causes & Symptoms

Clinical Causes: Repeated misuse or overuse of sedative, hypnotic, or anxiolytic medications without medical supervision. Dependence on these medications, leading to altered brain chemistry. Using these drugs recreationally or in higher doses than prescribed. Underlying mental health issues such as anxiety or insomnia, which may lead to misuse. Lack of awareness about the potential side effects of these medications.

Key Symptoms: Sexual dysfunction, including reduced libido, erectile difficulties, or decreased arousal. Signs of sedative, hypnotic, or anxiolytic misuse such as drowsiness, confusion, or impaired coordination. Emotional changes such as irritability, anxiety, or depression. Dependence symptoms like craving, tolerance, or withdrawal when not using the substance. Poor concentration or memory problems.

Diagnostic & Treatment

Diagnosis Path: Diagnosing this condition typically involves a thorough medical history and physical examination. Healthcare providers may inquire about medication use, substance intake patterns, and sexual health concerns. Laboratory tests or toxicology screenings can help determine if sedative, hypnotic, or anxiolytic drugs are involved. Mental health assessments may also be used to identify underlying issues contributing to substance misuse and sexual dysfunction.

Treatment Protocols: Medical detoxification under supervision if there is dependence or withdrawal risk. Medication management to address substance dependence and reduce cravings. Psychotherapy such as cognitive-behavioral therapy (CBT) to modify substance use behaviors and address underlying mental health issues. Counseling to improve sexual health and address related concerns. Lifestyle modifications, including stress management and healthy sleep habits. Support groups or rehabilitation programs for ongoing support and accountability.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F13.181 a billable ICD-10 code?
Yes, F13.181 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F13.181?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction and any associated comorbidities for accurate reporting.

Cite this Clinical Reference